Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -72.52% is 70% above its 5-year average of -240.26%, near the high end of its 5-year range (-659.14%–-72.52%).
As of the fiscal period ended Wednesday, December 31, 2025. 10.04% above its 12-month average of -80.61%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -29.90%.
RETURN ON ASSETS (ROA)
-72.52%
RETURN ON ASSETS (ROA) AVG TTM
-80.61%
RETURN ON ASSETS (ROA) AVG 3Y
-249.55%
RETURN ON ASSETS (ROA) AVG 5Y
-240.26%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.04%
CURRENT VS 3Y AVG
+70.94%
CURRENT VS 5Y AVG
+69.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.79%
median of 811 covered companies
CURRENT VS SECTOR MEDIAN
-128.12%
vs the sector median at left
NewcelX Ltd.
Market Cap
$1.32M
Return on Assets (ROA)
-72.52%
TTM Avg
-80.61%
3Y Avg
-249.55%
5Y Avg
-240.26%
Market Cap
$1.33M
Return on Assets (ROA)
-96.27%
TTM Avg
-335.81%
3Y Avg
-263.87%
5Y Avg
-193.48%
Market Cap
$1.34M
Return on Assets (ROA)
-247.39%
TTM Avg
-97.35%
3Y Avg
-1378.80%
5Y Avg
-1078.71%
Market Cap
$1.37M
Return on Assets (ROA)
-196.18%
TTM Avg
-334.48%
3Y Avg
-197.38%
5Y Avg
-169.68%
Market Cap
$1.42M
Return on Assets (ROA)
-23.39%
TTM Avg
-29.27%
3Y Avg
-34.02%
5Y Avg
-43.63%
Market Cap
$1.44M
Return on Assets (ROA)
-20.46%
TTM Avg
-67.47%
3Y Avg
-117.99%
5Y Avg
-101.96%
Market Cap
$1.16M
Return on Assets (ROA)
-147.60%
TTM Avg
-223.87%
3Y Avg
-1843.76%
5Y Avg
-4349.14%
Market Cap
$1.49M
Return on Assets (ROA)
-36.88%
TTM Avg
-64.67%
3Y Avg
-76.84%
5Y Avg
-289.12%
Market Cap
$1.15M
Return on Assets (ROA)
-64.99%
TTM Avg
-31.34%
3Y Avg
-98.36%
5Y Avg
-79.15%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewcelX Ltd. (NCEL) | $1.32M | -72.52% | -80.61% | -249.55% | -240.26% |
| Genprex, Inc. (GNPX)vs › | $1.33M | -96.27% | -335.81% | -263.87% | -193.48% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.34M | -247.39% | -97.35% | -1378.80% | -1078.71% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.37M | -196.18% | -334.48% | -197.38% | -169.68% |
| NEXGEL, Inc. (NXGL)vs › | $1.42M | -23.39% | -29.27% | -34.02% | -43.63% |
| INVO Fertility, Inc. (IVF)vs › | $1.44M | -20.46% | -67.47% | -117.99% | -101.96% |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.16M | -147.60% | -223.87% | -1843.76% | -4349.14% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -36.88% | -64.67% | -76.84% | -289.12% |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | -64.99% | -31.34% | -98.36% | -79.15% |
| Curis, Inc. (CRIS)vs › | $1.50M | -111.51% | -71.56% | -64.13% | -49.86% |
ROA
-72.5%
ROE
-114.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -72.52% |
| 2024-12-31 | -88.70% |
| 2023-12-31 | -659.14% |
| 2022-12-31 | -177.82% |
| 2021-12-31 | -207.23% |
| 2020-12-31 | -236.17% |
| 2019-12-31 | -782.15% |
| 2018-12-31 | -3.53% |
| 2017-12-31 | -290.94% |
